Intelligence / Healthtech / PMA Approvals / Centinel Spine, LLC
Approvalsdevice change approved (PMA)9 Sept 2026
Centinel Spine, LLC
9 Sept 2026: Device change approved (PMA) · prodisc® C Nova. Recorded in the openFDA device PMA data.
- Decided
- 9 Sept 2026
- Device
- prodisc® C Nova
- Specialty
- Orthopedic
- Type
- Supplement (Normal 180 Day Track)
- Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Reference
- P070001 S031
- Location
- West Chester, PA
What this signal means
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Centinel Spine, LLC
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Centinel Spine, LLC in our registers.
More in Orthopedic
PMA Approvals
22 SeptSpineart USA, INC.device change approved (PMA) · BAGUERA®C Cervical Disc ProsthesisApprovals21 SeptDepuy, INC.device change approved (PMA) · Attune Revision Knee SystemApprovals26 AugMedtronic Sofamor Danek USA, INC.device change approved (PMA) · INFUSE BONE GRAFTApprovals26 AugMedtronic Sofamor Danek USA, INC.device change approved (PMA) · INFUSE BONE GRAFT/LT-CAGE LUMBAR TAPERED FUSION DEVICEApprovals
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.